Arrowstreet Capital
RXDX

Arrowstreet Capital’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Arrowstreet Capital’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,684
Closed -$441K – 1484
2022
Q1 		$441K Buy
+11,684
New +$441K ﹤0.01% 1048